Trials / Completed
CompletedNCT02510482
Biological Variation of Cardiac Biomarkers in Aortic Valve Stenosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Calcified aortic valve stenosis (CAVS) is a progressive disease and nowadays, the cornerstone in diagnostics and follow-up is echocardiography. Cardiac biomarkers (such as cardiac troponins T and I and NT-pro-BNP) hold promise to fulfil a role in early recognition of complications concerning the aortic valve and decompensation. For this purpose, it is important to assess the normal biological variation (BV) of cardiac biomarkers in CAVS. The assessment of biological variation will contribute to a better understanding of fluctuation of cardiac biomarkers in subjects with stable CAVS. These data will improve monitoring of CAVS using cardiac biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2017-10-16
- Completion
- 2017-10-16
- First posted
- 2015-07-29
- Last updated
- 2017-10-18
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02510482. Inclusion in this directory is not an endorsement.